Ads
-
Related paper
- Lung Cancer: Biomarkers, Tyrosine Kinase Inhibitors and Monoclonal Antibodies
- Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
- In silico screening of 3,4 dihydropyrimidones as focal adhesion tyrosine kinase inhibitors
- CHRONIC MYELOID LEUKEMIA STUDY FOR RESPONSE PATTERN WITH TYROSINE KINASE INHIBITORS
- QSAR APPROACH TO THE STUDY OF THE EGFR TYROSINE KINASE INHIBITORS: THIAZOLYL-PYRAZOLINE DERIVATIVES
- Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia
- Efficacy and Toxicity Assessment of Different Clinically Used Small Molecular Tyrosine Kinase Inhibitors by Computational Molecular Docking Method
- Design, Synthesis and Biological Evaluation of Some New Derivatives of Azoles Bearing Pyrrolo [2, 3-d] Pyrimidine Nucleus as Janus Tyrosine Kinase Inhibitors for the Treatment of Auto Immune Disease
- Structure-Based Identification of Some Potential Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) With In-silico Assessment of Their Pharmacokinetic Features and Quantum Chemical Calculations
- TARGETING MONOCLONAL ANTIBODIES TO THE TUMOR MICROENVIRONMENT FOR CANCER THERAPY/IMMUNOTHERAPY